收藏切换
Dengzhan Shengmai inhibits nonalcoholic fatty liver disease via regulating intestinal microenvironment
收藏切换
PDF
Hui-hui GUO1, Hao-ran SHEN1, Hong-juan ZHANG1, Lu-lu WANG2, *, Yan-xing HAN1, *, Jian-dong JIANG1, 2
Acta Pharmaceutica Sinica | 2022, 57(12) : 3524 - 3534
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(12): 3524-3534
Special Reports: Therapeutic Modulation of Gut Immune and Microbiota Homeostasis by Chinese Medicine
Dengzhan Shengmai inhibits nonalcoholic fatty liver disease via regulating intestinal microenvironment
Full
Hui-hui GUO1, Hao-ran SHEN1, Hong-juan ZHANG1, Lu-lu WANG2, *, Yan-xing HAN1, *, Jian-dong JIANG1, 2
Affiliations
  • 1. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2022-12-12 doi: 10.16438/j.0513-4870.2022-0908
Outline
收藏切换

The aim of this study was to investigate the efficacy and mechanism of Dengzhan Shengmai (DZSM) against nonalcoholic fatty liver diseases (NAFLD). The animal experiment program was reviewed and approved by the Ethics Committee of Institute of Materia Medica, Chinese Academy of Medical Sciences. The NAFLD model of Syrian golden hamsters was established by high fat diets. After 6 weeks of DZSM treatment, the serum lipid, hepatic lipid accumulation, liver function and inflammatory response were determined. The regulations of gut microbiota and short-chain fatty acids were detected by 16S rRNA gene sequencing and gas chromatography-mass spectrometry method, respectively. The gut barrier function was evaluated by enzyme linked immunosorbent assay (ELISA), reverse transcription-quantitative polymerase chain reaction (RT-qPCR), Western blot and histopathological methods and further verified in HepG2 cells. The results showed that the efficacy of DZSM against NAFLD was remarkably reduced after removal of the gut microbiota. The study of mechanism showed that DZSM significantly regulated the composition of gut microbiota, promoted the production and absorption of intestinal short-chain fatty acids, then leading to the reduction of hepatic lipid accumulation. Moreover, after DZSM treatment, the decreased lipopolysaccharide (LPS) level by improving the intestinal barrier function significantly inhibited the hepatic inflammation through down-regulating Toll like receptor 4 (TLR4)-nuclear factor kappa B (NFKB) signaling pathway. These results indicate that DZSM inhibits NAFLD via regulating intestinal microenvironment.

Dengzhan Shengmai  /  nonalcoholic fatty liver disease  /  gut microbiota  /  short-chain fatty acid  /  lipopolysaccharide
Hui-hui GUO, Hao-ran SHEN, Hong-juan ZHANG, Lu-lu WANG, Yan-xing HAN, Jian-dong JIANG. Dengzhan Shengmai inhibits nonalcoholic fatty liver disease via regulating intestinal microenvironment[J]. Acta Pharmaceutica Sinica, 2022 , 57 (12) : 3524 -3534 . DOI: 10.16438/j.0513-4870.2022-0908
Year 2022 volume 57 Issue 12
PDF
180
73
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-0908
  • Receive Date:2022-07-25
  • Online Date:2025-12-24
  • Published:2022-12-12
Article Data
Affiliations
History
  • Received:2022-07-25
  • Revised:2022-08-26
Funding
Affiliations
    1. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-0908
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT